RenovoRx Inc

RenovoRx Inc(RNXT)價格預測

$1.135

-0.052 (-4.62%)收盤時

價格預測

1-Day Price Prediction
-0.91%
1-Week Prediction
-4.05%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

RNXT 相似圖表分析預測

Alphio's RNXT stock price prediction model matches the current RenovoRx Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.12 (-0.91%). The 1-week path is $1.09 (-4.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 RenovoRx Inc 股票嗎?

RenovoRx Inc is a good buy right now due to its recent strong revenue growth and positive clinical trial results. The stock closed at $1.26, which is significantly below the analyst price target of $14.50, indicating a potential upside of over 1,000%. Additionally, the company reported a record revenue of $909,000 for Q2 2026, reflecting a 61% sequential increase and a 115% year-over-year rise. The main risk is the negative earnings per share (EPS) of -0.06 reported for Q2 2026, which indicates ongoing losses but is improving compared to previous quarters.

RNXT 股價於 Friday 收在 $1.14,此前下跌 -4.62%

RenovoRx Inc (RNXT) last closed at $1.135, losing -4.62%. These facts feed the 1-day and 1-week RNXT price prediction above.

預測驅動因素

RenovoRx Inc(RNXT)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Positive

Bullish

相似圖表形態

近期走勢與 RNXT 最接近的股票,依相似度排序。

RNXT 季節性分析

Historically the probability of a positive November return for RNXT is 11.36%. June offers the highest probability of a positive month at 53.33%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易